Proposal for a new inclusive designation for extraintestinal pathogenic isolates of Escherichia coli: ExPEC

Journal of Infectious Diseases

Volumn 181, Issue 5, 2000, Pages 1753-1754

  Russo, Thomas A ^b   Johnson, James R ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL INFECTION; BACTEREMIA; BACTERIUM ISOLATE; COLITIS; ESCHERICHIA COLI; GASTROENTERITIS; GRAM NEGATIVE INFECTION; MENINGITIS; NONHUMAN; OSTEOMYELITIS; PNEUMONIA; PRIORITY JOURNAL; SHORT SURVEY; SOFT TISSUE INFECTION; URINARY TRACT INFECTION;

ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; VIRULENCE;

EID: 0034041230     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315418     Document Type: Short Survey

References (14)

1. 1. Herzer PJ, Inouye S, Inouye M, Whittam TS. Phylogenetic distribution of branched RNS-linked multicopy single-stranded DNA among natural isolates of Escherichia coli. J Bacteriol 1990;172:6175-81.
2. 2. Selander RK, Caugant DA, Whittam TS. Genetic structure and variation in natural populations of Escherichia coli. In: Neidhardt F, Ingraham JL, Low KB, Magasanik B, Schaechter M, Umbarger HE, eds. Escherichia coli and Salmonella typhimurium: cellular and molecular biology. Washington, DC: American Society for Microbiology, 1987:1625-48.
3. 3. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998;11:142-201 (erratum: Clin Microbiol Rev 1998;11:403).
4. 4. Gransden WR, Eykyn SJ, Phillips I, Rowe B. Bacteremia due to Escherichia coli: a study of 861 episodes. Rev Infect Dis 1990;12:1008-18.
5. 5. Roberts F, Geere IW, Coldman A. A three-year study of positive blood cultures, with emphasis on prognosis. Rev Infect Dis 1991;13:34-46.
6. 6. Sussman M, ed. Escherichia coli: mechanisms of virulence. In: Escherichia coli and human disease. Cambridge: Cambridge University Press, 1997.
7. 7. Eisenstein BI, Jones GW. The spectrum of infections and pathogenic mechanisms of Escherichia coli. Adv Intern Med 1988;33:231-52.
8. 8. Johnson JR. Virulence factors in Escherichia coli urinary tract infections. Clin Microbiol Rev 1991;4:80-128.
9. 9. Finlay BB, Falkow S. Common themes in microbial pathogenicity revisited. Microbiol Mol Biol Rev 1997;61:136-69.
10. 10. Picard B, Sevali Garcia J, Gouriou S, et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 1999;67:546-53.
11. 11. Russo TA, Brown JJ, Jodush ST, Johnson JR. The O4 specific antigen moiety of lipopolysaccharide but not the K54 group 2 capsule is important for urovirulence in an extraintestinal isolate of Escherichia coli. Infect Immun 1996;64:2343-8.
12. 12. Russo TA, Liang Y, Cross AS. The presence of K54 capsular polysaccharide increases the pathogenicity of Escherichia coli in vivo. J Infect Dis 1994;169:112-8.
13. 13. Hacker J, Blum-Oehler G, Muhldorfer I, Tschape H. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol Microbiol 1997;23:1089-97.
14. 14. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000;181:261-72.